Richard C. Shelton, MD

Educational Activity

Crisis of Confidence: Antidepressant Risk Versus Benefit

March 15, 2011

Original Research

A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression

February 22, 2011

Article

Long-Term Management of Depression: Tips for Adjusting the Treatment Plan as the Patient's Needs Change

November 15, 2009

Article

St John's Wort (Hypericum perforatum) in Major Depression

November 15, 2009

Original Research

The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies

October 31, 2008

Original Research

Are Depressed Outpatients With and Without a Family History of Substance Use Disorder Different? A Baseline Analysis of the STAR*D Cohort

December 14, 2007

Letter to the Editor

Reply to Sertraline Versus Venlafaxine XR in Major Depressive Disorder

October 15, 2007

Original Research

The Prevention of Recurrent Episodes of Depression With Venlafaxine for Two Years (PREVENT) Study: Outcomes From the 2-Year and Combined Maintenance Phases

August 15, 2007

Article

Augmentation Strategies to Increase Antidepressant Efficacy

August 15, 2007

Original Research

Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study

July 16, 2007

Original Research

Efficacy and Tolerability of Adjunctive Ziprasidone in Treatment-Resistant Depression: A Randomized, Open-Label, Pilot Study

July 16, 2007

Original Research

Augmentation of Antidepressants With Atypical Antipsychotic Medications for Treatment-Resistant Major Depressive Disorder: A Meta-Analysis

June 15, 2007